- Home
- COEP vs TPCS Comparison
COEP vs TPCS Comparison
Compare COEP & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COEP | TPCS |
|---|---|---|
| Founded | 2017 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 40.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | COEP | TPCS |
|---|---|---|
| Price | $14.02 | $4.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 115.1K | 31.2K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $500,996.00 | ★ $33,564,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.15 |
| 52 Week Low | $2.31 | $2.05 |
| 52 Week High | $21.41 | $6.25 |
Technical Indicators
Market Signals| Indicator | COEP | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 44.01 | 53.59 |
| Support Level | $13.61 | $4.24 |
| Resistance Level | $14.88 | $4.74 |
| Average True Range (ATR) | 1.17 | 0.24 |
| MACD | -0.22 | 0.04 |
| Stochastic Oscillator | 31.95 | 85.51 |
Price Performance
Historical ComparisonAbout COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About TPCS TechPrecision Corporation
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.